Initially, we examined the expression levels of key genes within the innate immune pathway, namely DDX58, MAVS, C6orf150, TMEM173, IKBKE, TBK1 and IRF3, across diverse tumor and non-tumor tissues. This evidence concerns the gene MAVS and neoplasm.